부광약품
ABOUT BUKWANG
Company Introduction
Vision & Mission
History
Manufacturing Facilities
Subsidiaries & Affiliates
Contact us
R&D
R&D Facilities
Pipeline
Latuda
JM-010
CP-012
Open Innovation
NEWS
IR
Financial Information
IR Reports
ANNUAL REPORT
PRODUCTS
Product Search
ETC
OTC
Health Functional Food
Personal Care Products
HOME
CONTACT US
KR
KR
EN
ABOUT BUKWANG
Company Introduction
Vision & Mission
History
Manufacturing Facilities
Subsidiaries & Affiliates
Contact us
R&D
R&D Facilities
Pipeline
Latuda
JM-010
CP-012
Open Innovation
JaguAhr
Protekt
NEWS
News
IR
Financial Information
IR Reports
ANNUAL REPORT
PRODUCTS
Product Search
ETC
OTC
Health Functional Food
Personal Care Products
NEWS
HOME
NEWS
NEWS
NEWS
ALL
Company news
Product news
R&D news
R&D news | Bukwang Pharmaceutical Co., Ltd. received 5.8 B KRW from its..
On March 28th 2017, Bukwang Pharmaceutical Co., Ltd.(“Bukwang”) announced that i..
2017.03.28
R&D news | Bukwang Pharmaceutical Co., Ltd. LID treatment ‘JM-010’ is a..
Bukwang recently announced that Ministry of Food and Drug Safety (MFDS) has gran..
2017.01.05
R&D news | Bukwang launched cosmetic products to target Dermocosmetic ..
Bukwang Pharmaceutical Co., Ltd., is now ready to enter into new industry by imp..
2017.01.04
R&D news | Bukwang Pharmaceutical Co., Ltd, submitted Phase 2b IND for ..
Bukwang Pharmaceuticals Co., Ltd. (Bukwang) announced that it has submitted to M..
2016.12.19
R&D news | First patient dosed in pharmacokinetic clinical trial of JM..
Bukwang Pharm. announced that first dosing of the pharmacokinetic clinical trial..
2016.08.09
R&D news | First patient dosed in pharmacokinetic clinical trial of JM..
Bukwang Pharm. announced that first dosing of the pharmacokinetic clinical trial..
2016.08.09
6
7
8